Global Medicine and Food Homologous Products Market 2026 by Company, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Medicine and Food Homologous Products by Type
- 1.3.1 Overview: Global Medicine and Food Homologous Products Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Medicine and Food Homologous Products Consumption Value Market Share by Type in 2025
- 1.3.3 Health Pills
- 1.3.4 Health Balm
- 1.3.5 Herbal Diet and Healthy Soup
- 1.3.6 Others
- 1.4 Global Medicine and Food Homologous Products Market by Application
- 1.4.1 Overview: Global Medicine and Food Homologous Products Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Online Sales
- 1.4.3 Offline Sales
- 1.5 Global Medicine and Food Homologous Products Market Size & Forecast
- 1.6 Global Medicine and Food Homologous Products Market Size and Forecast by Region
- 1.6.1 Global Medicine and Food Homologous Products Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Medicine and Food Homologous Products Market Size by Region, (2021-2032)
- 1.6.3 North America Medicine and Food Homologous Products Market Size and Prospect (2021-2032)
- 1.6.4 Europe Medicine and Food Homologous Products Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Medicine and Food Homologous Products Market Size and Prospect (2021-2032)
- 1.6.6 South America Medicine and Food Homologous Products Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Medicine and Food Homologous Products Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Renhe Group
- 2.1.1 Renhe Group Details
- 2.1.2 Renhe Group Major Business
- 2.1.3 Renhe Group Medicine and Food Homologous Products Product and Solutions
- 2.1.4 Renhe Group Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Renhe Group Recent Developments and Future Plans
- 2.2 Xxdun
- 2.2.1 Xxdun Details
- 2.2.2 Xxdun Major Business
- 2.2.3 Xxdun Medicine and Food Homologous Products Product and Solutions
- 2.2.4 Xxdun Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Xxdun Recent Developments and Future Plans
- 2.3 LaoJin MoFang
- 2.3.1 LaoJin MoFang Details
- 2.3.2 LaoJin MoFang Major Business
- 2.3.3 LaoJin MoFang Medicine and Food Homologous Products Product and Solutions
- 2.3.4 LaoJin MoFang Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 LaoJin MoFang Recent Developments and Future Plans
- 2.4 YAN PALACE
- 2.4.1 YAN PALACE Details
- 2.4.2 YAN PALACE Major Business
- 2.4.3 YAN PALACE Medicine and Food Homologous Products Product and Solutions
- 2.4.4 YAN PALACE Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 YAN PALACE Recent Developments and Future Plans
- 2.5 Zhengguanzhuang
- 2.5.1 Zhengguanzhuang Details
- 2.5.2 Zhengguanzhuang Major Business
- 2.5.3 Zhengguanzhuang Medicine and Food Homologous Products Product and Solutions
- 2.5.4 Zhengguanzhuang Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Zhengguanzhuang Recent Developments and Future Plans
- 2.6 Tong Ren Tang
- 2.6.1 Tong Ren Tang Details
- 2.6.2 Tong Ren Tang Major Business
- 2.6.3 Tong Ren Tang Medicine and Food Homologous Products Product and Solutions
- 2.6.4 Tong Ren Tang Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Tong Ren Tang Recent Developments and Future Plans
- 2.7 QILI XIANG
- 2.7.1 QILI XIANG Details
- 2.7.2 QILI XIANG Major Business
- 2.7.3 QILI XIANG Medicine and Food Homologous Products Product and Solutions
- 2.7.4 QILI XIANG Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 QILI XIANG Recent Developments and Future Plans
- 2.8 Comvita
- 2.8.1 Comvita Details
- 2.8.2 Comvita Major Business
- 2.8.3 Comvita Medicine and Food Homologous Products Product and Solutions
- 2.8.4 Comvita Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Comvita Recent Developments and Future Plans
- 2.9 Lei Yunshang Group
- 2.9.1 Lei Yunshang Group Details
- 2.9.2 Lei Yunshang Group Major Business
- 2.9.3 Lei Yunshang Group Medicine and Food Homologous Products Product and Solutions
- 2.9.4 Lei Yunshang Group Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Lei Yunshang Group Recent Developments and Future Plans
- 2.10 JIMON GROUP
- 2.10.1 JIMON GROUP Details
- 2.10.2 JIMON GROUP Major Business
- 2.10.3 JIMON GROUP Medicine and Food Homologous Products Product and Solutions
- 2.10.4 JIMON GROUP Medicine and Food Homologous Products Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 JIMON GROUP Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Medicine and Food Homologous Products Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Medicine and Food Homologous Products by Company Revenue
- 3.2.2 Top 3 Medicine and Food Homologous Products Players Market Share in 2025
- 3.2.3 Top 6 Medicine and Food Homologous Products Players Market Share in 2025
- 3.3 Medicine and Food Homologous Products Market: Overall Company Footprint Analysis
- 3.3.1 Medicine and Food Homologous Products Market: Region Footprint
- 3.3.2 Medicine and Food Homologous Products Market: Company Product Type Footprint
- 3.3.3 Medicine and Food Homologous Products Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Medicine and Food Homologous Products Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Medicine and Food Homologous Products Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Medicine and Food Homologous Products Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Medicine and Food Homologous Products Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Medicine and Food Homologous Products Consumption Value by Type (2021-2032)
- 6.2 North America Medicine and Food Homologous Products Market Size by Application (2021-2032)
- 6.3 North America Medicine and Food Homologous Products Market Size by Country
- 6.3.1 North America Medicine and Food Homologous Products Consumption Value by Country (2021-2032)
- 6.3.2 United States Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 6.3.3 Canada Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Medicine and Food Homologous Products Consumption Value by Type (2021-2032)
- 7.2 Europe Medicine and Food Homologous Products Consumption Value by Application (2021-2032)
- 7.3 Europe Medicine and Food Homologous Products Market Size by Country
- 7.3.1 Europe Medicine and Food Homologous Products Consumption Value by Country (2021-2032)
- 7.3.2 Germany Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 7.3.3 France Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 7.3.5 Russia Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 7.3.6 Italy Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Medicine and Food Homologous Products Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Medicine and Food Homologous Products Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Medicine and Food Homologous Products Market Size by Region
- 8.3.1 Asia-Pacific Medicine and Food Homologous Products Consumption Value by Region (2021-2032)
- 8.3.2 China Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 8.3.3 Japan Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 8.3.5 India Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 8.3.7 Australia Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Medicine and Food Homologous Products Consumption Value by Type (2021-2032)
- 9.2 South America Medicine and Food Homologous Products Consumption Value by Application (2021-2032)
- 9.3 South America Medicine and Food Homologous Products Market Size by Country
- 9.3.1 South America Medicine and Food Homologous Products Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Medicine and Food Homologous Products Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Medicine and Food Homologous Products Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Medicine and Food Homologous Products Market Size by Country
- 10.3.1 Middle East & Africa Medicine and Food Homologous Products Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
- 10.3.4 UAE Medicine and Food Homologous Products Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Medicine and Food Homologous Products Market Drivers
- 11.2 Medicine and Food Homologous Products Market Restraints
- 11.3 Medicine and Food Homologous Products Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Medicine and Food Homologous Products Industry Chain
- 12.2 Medicine and Food Homologous Products Upstream Analysis
- 12.3 Medicine and Food Homologous Products Midstream Analysis
- 12.4 Medicine and Food Homologous Products Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Medicine and Food Homologous Products market size was valued at US$ 1147 million in 2025 and is forecast to a readjusted size of US$ 1545 million by 2032 with a CAGR of 4.4% during review period.
Medicinal and edible homologous substances are substances that are both food and Chinese medicinal materials according to tradition.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Medicine and Food Homologous Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medicine and Food Homologous Products market size and forecasts, in consumption value ($ Million), 2021-2032
Global Medicine and Food Homologous Products market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Medicine and Food Homologous Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Medicine and Food Homologous Products market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medicine and Food Homologous Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medicine and Food Homologous Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Renhe Group, Xxdun, LaoJin MoFang, YAN PALACE, Zhengguanzhuang, Tong Ren Tang, QILI XIANG, Comvita, Lei Yunshang Group, JIMON GROUP, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Medicine and Food Homologous Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Health Pills
Health Balm
Herbal Diet and Healthy Soup
Others
Market segment by Application
Online Sales
Offline Sales
Market segment by players, this report covers
Renhe Group
Xxdun
LaoJin MoFang
YAN PALACE
Zhengguanzhuang
Tong Ren Tang
QILI XIANG
Comvita
Lei Yunshang Group
JIMON GROUP
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Medicine and Food Homologous Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medicine and Food Homologous Products, with revenue, gross margin, and global market share of Medicine and Food Homologous Products from 2021 to 2026.
Chapter 3, the Medicine and Food Homologous Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Medicine and Food Homologous Products market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medicine and Food Homologous Products.
Chapter 13, to describe Medicine and Food Homologous Products research findings and conclusion.